Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Breast 1

Conditions

Lymphoma 4Breast Neoplasms 4Uterine Cervical Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neutropenia 1Multiple Myeloma 1Malignant Solid Tumors 1Lymphoma, Non-Hodgkin 1Hematologic Neoplasms 1Breastcancer 1Bone Neoplasms 1

Interventions

Ibandronic Acid 2pegylated granulocyte colony-stimulating factor 1Zoledronic Acid 1Pregabalin 1Kyphoplasty 1Enoxaparin 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Bone Neoplasms × pegylated granulocyte colony-stimulating factor × Clear all
NCT02905916 2016-09-19

The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy

Peking University

Phase 4 Unknown
217 enrolled
BreastLymphoidSarcoma

Bone Neoplasms, Breast Neoplasms, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡